Kala Pharmaceuticals Inc (KALA)

Currency in USD
0.199
-0.027(-11.96%)
Closed·
0.1990.000(0.20%)
·
KALA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1900.224
52 wk Range
0.14620.600
Key Statistics
Prev. Close
0.226
Open
0.224
Day's Range
0.19-0.224
52 wk Range
0.146-20.6
Volume
3.34M
Average Vol. (3m)
7.08M
1-Year Change
-94.3626%
Book Value / Share
-1.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KALA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Kala Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company’s lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Compare KALA to Peers and Sector

Metrics to compare
KALA
Peers
Sector
Relationship
P/E Ratio
−0.2x−4.3x−0.5x
PEG Ratio
0.000.140.00
Price / Book
−0.7x4.3x2.6x
Price / LTM Sales
-38.6x3.2x
Upside (Analyst Target)
-118.7%47.6%
Fair Value Upside
Unlock−4.7%6.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Mizuho
Hold1.50+653.77%30.00DowngradeSep 30, 2025
H.C. Wainwright
Hold---DowngradeSep 29, 2025
LifeSci Capital
Hold---DowngradeSep 29, 2025
Ladenburg Thalmann
Hold---DowngradeSep 29, 2025
H.C. Wainwright
Buy35.00+17,487.94%12.00MaintainSep 17, 2025

Earnings

Latest Release
Nov 19, 2025
EPS / Forecast
-1.07 / -2.81
Revenue / Forecast
-- / 10.4M
EPS Revisions
Last 90 days

KALA Income Statement

People Also Watch

1.230
QNCX
-1.60%
2.900
MOBX
+10.27%
0.9708
PRSO
+6.08%
0.5087
TPET
-0.25%
0.1450
ASNS
+8.12%

FAQ

What Is the Kala Pharma (KALA) Stock Price Today?

The Kala Pharma stock price today is 0.199 USD.

What Stock Exchange Does Kala Pharma Trade On?

Kala Pharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Kala Pharma?

The stock symbol for Kala Pharma is "KALA."

What Is the Kala Pharma Market Cap?

As of today, Kala Pharma market cap is 5.400M USD.

What Is Kala Pharma's Earnings Per Share (TTM)?

The Kala Pharma EPS (TTM) is -5.825.

From a Technical Analysis Perspective, Is KALA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kala Pharma Stock Split?

Kala Pharma has split 1 times.

How Many Employees Does Kala Pharma Have?

Kala Pharma has 38 employees.

What is the current trading status of Kala Pharma (KALA)?

As of Apr 15, 2026, Kala Pharma (KALA) is trading at a price of 0.199 USD, with a previous close of 0.226 USD. The stock has fluctuated within a day range of 0.190 USD to 0.224 USD, while its 52-week range spans from 0.146 USD to 20.600 USD.

What Is the KALA Premarket Price?

KALA's last pre-market stock price is 0.220 USD. The pre-market share volume is 217,910.000, and the stock has decreased by -0.006, or -2.650%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.